Eli Lilly & Co. (LLY)
1078.73
+0.98
(+0.09%)
USD |
NYSE |
Dec 29, 16:00
1078.04
-0.69
(-0.06%)
Pre-Market: 07:27
Eli Lilly EPS Diluted (Quarterly): 6.211 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Adverum Biotechnologies, Inc. | -2.029 |
| Viking Therapeutics, Inc. | -0.8083 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.582B |
| Revenue (Quarterly) | 17.60B |
| Total Expenses (Quarterly) | 12.02B |
| Enterprise Value | 998.13B |
| Gross Profit Margin (Quarterly) | 82.91% |
| Profit Margin (Quarterly) | 31.72% |
| Earnings Yield | 1.87% |
| Operating Earnings Yield | 2.68% |
| Normalized Earnings Yield | 2.093 |